Evidence map›Paper›PMID 41021180›Full record

ArticleCell biochemistry and biophysics2026

Networking Pharmacology and Integrated Bioinformatic Analysis of Hygrophila Auriculata for Lipid Metabolism Modulation in Type 2 Diabetes Mellitus.

Snega Saravanan, Edward Arockiasamy

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Snega SaravananDepartment of Biotechnology, St. Joseph's College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
Edward ArockiasamyDepartment of Biotechnology, St. Joseph's College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. edward_bt2@mail.sjctni.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 Diabetes Mellitus (T2DM) is a multifactorial metabolic disorder embedded in impaired adipose tissue function and underlying elements of altered lipid metabolism. Adipokines and lipid-processing enzymes play a critical role in the regulatory mechanisms of metabolic homeostasis. To report the possible modulators of lipid metabolism from Hygrophila auriculata via the integrated in silico approaches of network pharmacology, molecular docking, and dynamic simulations. The dedicated approach involved identifying phytochemicals from H. auriculata via GC-MS, followed by obtaining their physicochemical structures from PubChem. The ADMET profiling and drug-likeness of phytochemicals were screened using SWISS ADME and pkCSM. To retain biological relevance, putative protein targets were initially identified through network pharmacology analysis and hub-gene analysis, followed by molecular docking for the top-ranked diabetes-related targets to validate compound–protein binding interactions. Network pharmacology, utilising STRING and Cytoscape (with the CytoHubba plugin), was employed to identify hub genes. Molecular docking and MM-GBSA calculations were performed for T2DM-related targets (PPAR-γ, LIPE, ADIPOQ, LPL, APOB), and WaterMap were used to assess complex stability and binding interactions. Out of 73 phytocompounds, 13-docosenamide had the best combined ADMET data and showed strong binding affinities (−10.2 to −9.1 kcal/mol) to the primary targets. The docking studies showed that hydrophobic and hydrogen bonding interactions were favourable. Although the MD simulations of the complex showed excellent stability over 100 ns, the studies support its possible function as a modulator of adipokine function and lipid metabolism. 13-Docosenamide from H. auriculata shows promise as a multitargeted lipid metabolism regulator for the management of T2DM. The current study expands upon previous reports of crude H. auriculata extracts by identifying specific bioactive phytochemicals and confirming their multiple target interactions with adipokine-related proteins through network pharmacology, docking, and MD simulations, thus clearly delineating the precise mechanistic role of each compound in the regulation of diabetes. This bioinformatics approach is economical and provides a valuable pipeline for identifying new drug compounds with antidiabetic properties, while facilitating future in vitro and in vivo investigations.

Indexed as

Computational BiologyDiabetes Mellitus, Type 2Lipid MetabolismPlant ExtractsHumansMolecular Docking SimulationMolecular Dynamics SimulationNetwork PharmacologyPhytochemicalsPPAR gammaPhytochemicalsPlant ExtractsPPAR gammaMM-GBSAMolecular dockingNetwork pharmacologyPhytocompoundPubChemSWISS ADMEType 2 Diabetes mellitus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.